Skip to content

Drug interactions

Propafenone + Rimegepant

Severity: Moderate

Propafenone and Rimegepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rimegepant is a P-glycoprotein substrate, and propafenone's inhibition of this transporter may modestly increase rimegepant exposure. The expected effect is small, and rimegepant has a good tolerability profile.

What this interaction means in plain words

Propafenone and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Propafenone belongs to Cardiovascular; Rimegepant belongs to Central Nervous System.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by propafenone reduces rimegepant efflux and raises its exposure.

What to do

Avoid taking a second rimegepant dose within 48 hours when the patient is taking a P-gp inhibitor, as the labeling advises. Monitor for adverse effects such as nausea and hypersensitivity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Propafenone and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Propafenone with Rimegepant?

MediHelp rates the interaction as moderate. Propafenone and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rimegepant is a P-glycoprotein substrate, and propafenone's inhibition of this transporter may modestly increase rimegepant exposure. The expected effect is small, and rimegepant has a good tolerability profile.

How serious is the interaction between Propafenone and Rimegepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid taking a second rimegepant dose within 48 hours when the patient is taking a P-gp inhibitor, as the labeling advises. Monitor for adverse effects such as nausea and hypersensitivity.

What other medicines interact with Propafenone?

MediHelp also lists interactions of Propafenone with, for example, Dofetilide, Dronedarone, Nilotinib. The full list is on the Propafenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in